Genetic Protection Modifications: Moving Beyond the Binary Distinction Between Therapy and Enhancement for Human Genome Editing.
Journal
The CRISPR journal
ISSN: 2573-1602
Titre abrégé: CRISPR J
Pays: United States
ID NLM: 101738191
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
entrez:
21
12
2019
pubmed:
21
12
2019
medline:
21
7
2020
Statut:
ppublish
Résumé
The current debate and policy surrounding the use of genome editing in humans typically relies on a binary distinction between therapy and human enhancement. Here, we argue that this dichotomy fails to take into account perhaps the most significant potential uses of CRISPR-Cas9 genome editing in humans. We argue that genetic treatment of sporadic Alzheimer's disease, breast and ovarian cancer predisposing
Identifiants
pubmed: 31860350
doi: 10.1089/crispr.2019.0024
doi:
Substances chimiques
RNA, Guide
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM